BioSpace News Archive

Algernon Pharmaceuticals Inc. is pleased to announce that it has initiated an NP-120 (“Ifenprodil”) small cell lung cancer (“SCLC”) research program and has appointed Dr. William North, professor emeritus at Dartmouth College and cancer research pioneer, as lead consultant.

scPharmaceuticals Inc. today announced financial results for the second quarter ended June 30, 2021 and provided a business update.

Miromatrix Medical Inc., a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients’ lives and improve quality of life around the world, announced strategic investors involved in its Series C financing, which was followed by its June 24th IPO.

FibroGen, Inc. (NASDAQ: FGEN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for roxadustat for the treatment of anemia of chronic kidney disease (CKD).

PolyPid Ltd. today provided a corporate update and reported financial results for the three and six months ended June 30, 2021.

Viridian Therapeutics, Inc. today announced financial results for the second quarter ended June 30, 2021, and provided corporate updates.

Stryker, one of the world’s leading medical technology companies, announced the launch of SurgiCount™+ Safety-Sponge System, its next generation surgical sponge counting technology.

Of late, there has been an increasing awareness regarding the therapeutic potential of stem cells for management of diseases which is boosting the growth of the stem cell therapy market.

Nicotine gum and lozenges are both popular and convenient forms of nicotine replacement therapy.

The global mice model market is expanding on account of the striking relevance of these models in performing biomedical research.